Pulmonx Corp Files Q1 2025 10-Q
Ticker: LUNG · Form: 10-Q · Filed: May 2, 2025 · CIK: 1127537
| Field | Detail |
|---|---|
| Company | Pulmonx Corp (LUNG) |
| Form Type | 10-Q |
| Filed Date | May 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, healthcare
TL;DR
Pulmonx Q1 2025 10-Q filed. Financials look steady, no major red flags yet.
AI Summary
Pulmonx Corp filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including changes in common stock, additional paid-in capital, accumulated other comprehensive income, and retained earnings. The company is based in Redwood City, CA, and operates in the surgical and medical instruments sector.
Why It Matters
This filing provides investors with the latest financial performance and position of Pulmonx Corp, crucial for understanding the company's health and future prospects in the medical device market.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate indicators of significant risk or distress.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-02 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2024-12-31 — Previous Year End Date (Provides a comparison point for financial changes.)
Key Players & Entities
- Pulmonx Corp (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250502 (date) — Filing date
- Redwood City, CA (location) — Company headquarters
- Surgical & Medical Instruments & Apparatus (industry) — Company's Standard Industrial Classification
FAQ
What were the key changes in Pulmonx Corp's equity accounts during the first quarter of 2025?
The filing indicates changes in us-gaap:CommonStockMember, us-gaap:AdditionalPaidInCapitalMember, us-gaap:AccumulatedOtherComprehensiveIncomeMember, and us-gaap:RetainedEarningsMember for the period from January 1, 2025, to March 31, 2025.
What is Pulmonx Corp's primary business classification?
Pulmonx Corp is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' with the SIC code 3841.
Where is Pulmonx Corp headquartered?
Pulmonx Corp is headquartered at 700 Chesapeake Drive, Redwood City, CA 94063.
What is the fiscal year end for Pulmonx Corp?
Pulmonx Corp's fiscal year ends on December 31st.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 2, 2025 regarding Pulmonx Corp (LUNG).